Matilda Lee

483 total citations
16 papers, 338 citations indexed

About

Matilda Lee is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Matilda Lee has authored 16 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Matilda Lee's work include Cancer Immunotherapy and Biomarkers (4 papers), Advanced Breast Cancer Therapies (3 papers) and HER2/EGFR in Cancer Research (3 papers). Matilda Lee is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Advanced Breast Cancer Therapies (3 papers) and HER2/EGFR in Cancer Research (3 papers). Matilda Lee collaborates with scholars based in Singapore, Australia and Jordan. Matilda Lee's co-authors include Lingzhi Wang, Gautam Sethi, Andrea L.A. Wong, Boon-Cher Goh, Jayshree L. Hirpara, Sen Hee Tay, Yu Yang Soon, Soo Chin Lee, Raghav Sundar and Benjamin Kye Jyn Tan and has published in prestigious journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment and Redox Biology.

In The Last Decade

Matilda Lee

14 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matilda Lee Singapore 9 131 106 91 66 49 16 338
Dong Won Baek South Korea 10 126 1.0× 63 0.6× 36 0.4× 37 0.6× 29 0.6× 52 285
Tatsunori Kiriu Japan 13 199 1.5× 84 0.8× 119 1.3× 186 2.8× 57 1.2× 26 460
Aiping Ma China 11 59 0.5× 85 0.8× 110 1.2× 148 2.2× 26 0.5× 25 394
Doru Paul United States 9 221 1.7× 48 0.5× 100 1.1× 64 1.0× 57 1.2× 33 401
Kenneth Friedman United States 8 145 1.1× 36 0.3× 57 0.6× 41 0.6× 30 0.6× 14 286
Chang‐Suk Kang South Korea 12 82 0.6× 66 0.6× 97 1.1× 41 0.6× 29 0.6× 31 372
Birte Möhlendick Germany 14 217 1.7× 155 1.5× 134 1.5× 53 0.8× 162 3.3× 32 502
Ioannis P. Trontzas Greece 11 153 1.2× 79 0.7× 97 1.1× 88 1.3× 27 0.6× 32 338
Abhenil Mittal India 9 101 0.8× 108 1.0× 50 0.5× 74 1.1× 65 1.3× 53 325
Omar Pacha United States 11 173 1.3× 145 1.4× 84 0.9× 29 0.4× 13 0.3× 29 490

Countries citing papers authored by Matilda Lee

Since Specialization
Citations

This map shows the geographic impact of Matilda Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matilda Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matilda Lee more than expected).

Fields of papers citing papers by Matilda Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matilda Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matilda Lee. The network helps show where Matilda Lee may publish in the future.

Co-authorship network of co-authors of Matilda Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Matilda Lee. A scholar is included among the top collaborators of Matilda Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matilda Lee. Matilda Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Yau, Chun En, et al.. (2026). Glucagon-like peptide-1 receptor agonists and the risk of obesity-related cancers: a systematic review and meta-analysis. Diabetes Research and Clinical Practice. 234. 113158–113158.
2.
Walsh, Robert J., Matilda Lee, Natalie Y.L. Ngoi, et al.. (2024). Molecular profiling of metastatic breast cancer and target-based therapeutic matching in an Asian tertiary phase I oncology unit. Frontiers in Oncology. 14. 1342346–1342346.
3.
Huang, Yiqing, Joseph J. Zhao, Yu Yang Soon, et al.. (2022). Real‐world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non‐small cell lung cancer. Thoracic Cancer. 13(22). 3152–3161. 20 indexed citations
4.
Lim, Elaine Hsuen, Lavina Bharwani, Andrea Li Ann Wong, et al.. (2022). Real-world outcomes from use of CDK4/6 inhibitors in the management of advanced/metastatic breast cancer in Asia. Therapeutic Advances in Medical Oncology. 14. 4287551710–4287551710. 13 indexed citations
5.
Lim, Joline S.J., Joan Choo, Samuel G.W. Ow, et al.. (2021). Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancer. Breast Cancer Research and Treatment. 192(1). 131–142. 13 indexed citations
6.
Wong, Alvin, Balamurugan Vellayappan, Joseph J. Zhao, et al.. (2021). Atypical Response Patterns in Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors—Navigating the Radiologic Potpourri. Cancers. 13(7). 1689–1689. 11 indexed citations
7.
Chia, Daryl Kai Ann, Raghav Sundar, Guowei Kim, et al.. (2021). Outcomes of a phase II study of intraperitoneal paclitaxel plus systemic capecitabine and oxaliplatin (XELOX) for gastric cancer with peritoneal metastases.. Journal of Clinical Oncology. 39(3_suppl). 165–165. 6 indexed citations
8.
Zhao, Joseph J., Nesaretnam Barr Kumarakulasinghe, Matilda Lee, et al.. (2021). Low-Dose Nivolumab in Renal Cell Carcinoma: A Real-World Experience. Oncology. 99(3). 192–202. 16 indexed citations
9.
Lee, Ainsley Ryan Yan Bin, Shi Yin Wong, Louis Yi Ann Chai, et al.. (2021). Efficacy of COVID-19 vaccines in immunocompromised patients: A systematic review and meta-analysis. medRxiv. 115 indexed citations
10.
Lim, Joline S.J., Andrea Li Ann Wong, Samuel G.W. Ow, et al.. (2020). Clinical efficacy and molecular effects of lenvatinib (Len) and letrozole (Let) in hormone receptor-positive (HR+) metastatic breast cancer (MBC).. Journal of Clinical Oncology. 38(15_suppl). 1019–1019. 1 indexed citations
11.
Huang, Yiqing, Yvonne Ang, Wan Qin Chong, et al.. (2020). Cost and efficacy of low-dose pembrolizumab in the treatment of non-small cell lung cancer patients in Asia.. Journal of Clinical Oncology. 38(15_suppl). e19385–e19385. 2 indexed citations
12.
Lee, Matilda, Jayshree L. Hirpara, Gautam Sethi, et al.. (2018). Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors. Redox Biology. 25. 101073–101073. 104 indexed citations
13.
Lee, Matilda, et al.. (2018). The Role of Liver-Directed Therapy in Metastatic Colorectal Cancer. Current Colorectal Cancer Reports. 14(5). 129–137. 8 indexed citations
14.
Lee, Matilda, Andrea Li Ann Wong, Samuel G.W. Ow, et al.. (2018). Dose finding study of varlitinib ± trastuzumab with carboplatin/paclitaxel in advanced solid tumors.. Journal of Clinical Oncology. 36(15_suppl). 2588–2588. 1 indexed citations
15.
Lee, Matilda & David S.P. Tan. (2018). Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?. Journal of Gynecologic Oncology. 29(6). e96–e96. 18 indexed citations
16.
Bryant, Uneeda K., et al.. (2012). Congenital Aneurysmal Bone Cyst in a Foal. Journal of Equine Veterinary Science. 32(6). 320–323. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dong Won Baek Breakdown of academic impact, for papers by Tatsunori Kiriu Breakdown of academic impact, for papers by Aiping Ma Breakdown of academic impact, for papers by Doru Paul Breakdown of academic impact, for papers by Kenneth Friedman Breakdown of academic impact, for papers by Chang‐Suk Kang Breakdown of academic impact, for papers by Birte Möhlendick Breakdown of academic impact, for papers by Ioannis P. Trontzas Breakdown of academic impact, for papers by Abhenil Mittal Breakdown of academic impact, for papers by Omar Pacha
Rankless by CCL
2026